𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peripheral neuropathy with infliximab therapy in inflammatory bowel disease

✍ Scribed by D.C. Burger; T.H.J. Florin


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
44 KB
Volume
15
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Are accelerated infliximab infusions saf
✍ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD

Optimizing thiopurine therapy in inflamm
✍ Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet; Miles P. Sparrow πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

Despite recent advances, the therapeutic armamentarium for inflammatory bowel disease (IBD) is still limited. In addition, a step-up approach is recommended for most IBD patients. Thus, optimizing each medical therapy before switching to another drug class is the rule in clinical practice. Conventio

MRI in patients with inflammatory bowel
✍ Michael S. Gee; Mukesh G. Harisinghani πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 339 KB πŸ‘ 2 views

## Abstract Inflammatory bowel disease (IBD) affects β‰ˆ1.4 million people in North America and, because of its typical early age of onset and episodic disease course, IBD patients often undergo numerous imaging studies over the course of their lifetimes. Computed tomography (CT) has become the stand